Hanson Wade Group have taken the decision to cancel this meeting. Please do accept our apologies for any inconvenience or disappointment this will cause. Please register your interest here if you would like updates on the meeting or topic.
Welcome to the Complex Bioengineering for Cell Therapies Summit
Harnessing Molecular Biology For Multi-Targeted & Inducible Cell Therapies
What?
The Complex Bioengineering for Cell Therapies Summit is the only event focused on the latest molecular enhancement and modification technologies that boost potency, safety, and solid tumor infiltration across many cell types and diseases. This event offers insider knowledge from the pioneers integrating logic-gated and inducible cell therapies into their programs, completely reshaping therapeutic outcomes.
Why?
With the FDA’s landmark approval of Tecelra, the first cell therapy for solid tumors, it’s clear that cell therapies can reach a broader patient population. But to truly unleash the potential of these treatments, we must overcome key challenges. This summit gives unparalleled access to cutting-edge research to overcome these hurdles and lead us to more effective, potent, and safer therapies.
Who?
This conference is tailored for molecular biologists, bioengineers, R&D leaders, and developers committed to advancing the science and technology of cell therapies. Be part of a hands-on community of experts, working together to solve key challenges like specificity, in vivo persistence, and vector delivery. Take this opportunity to ensure your work stays at the cutting edge of this fast-evolving cell therapy field.
Other Events in the Series:
